CNS Pharmaceuticals, Inc. (CNSP) NASDAQ
4.92
-0.11(-2.19%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.33M |
| Enterprise Value | -4.54M |
| P/E Ratio | -0.21 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 48.28 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.01 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -3.54 |
| Return On Equity | -2.39 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -15.83M |
| Net Income | -15.85M |
| Diluted EPS | -35.75 |
Balance Sheet
| Total Cash | 2.95M |
| Total Cash/Share | 4.36 |
| Total Debt | 232,353 |
| Total Debt/Equity | 3.29 |
| Current Ratio | 0.88 |
| Book Value Per Share | 0.1 |
Price History
| 52-Week Change | -57.93 |
| 52-Week High | 12.96 |
| 52-Week Low | 1.9 |
| Moving Average 50 Days | 3.76 |
| Moving Average 200 Days | 5.69 |
Statistics
| Average Volume | 1.42M |
| Shares Outstanding | 574,580 |
| % Held by Institutions | 21.53 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | July 22, 2025 |
